Cross-cultural adaptation and validation of the Brazilian version of the Scleroderma Health Assessment Questionnaire (SHAQ)

被引:0
作者
Luiza F. Rocha
Roberta G. Marangoni
Percival D. Sampaio-Barros
Mauricio Levy-Neto
Natalino H. Yoshinari
Eloisa Bonfa
Virginia Steen
Sergio C. Kowalski
机构
[1] Universidade de São Paulo,Disciplina de Reumatologia, Faculdade de Medicina
[2] Northwestern University,Division of Rheumatology
[3] Georgetown University,Division of Rheumatology
[4] McMaster University,Health Research Methodology, Faculty of Health Sciences
来源
Clinical Rheumatology | 2014年 / 33卷
关键词
Health Assessment Questionnaire; Quality of life; SF-36; Systemic sclerosis;
D O I
暂无
中图分类号
学科分类号
摘要
The Scleroderma Health Assessment Questionnaire (SHAQ) is a feasible multisystem specific tool that has been extensively used as an additional assessment for systemic sclerosis (SSc). The aim of this study is to cross-culturally adapt and validate the Brazilian version of the SHAQ. Construct validity was assessed based on the correlations between SHAQ and both the Medical Outcomes Survey Short Form 36 version 2 (SF-36v2™) and the Health Assessment Questionnaire Disability Index (HAQ-DI). The correlation between the SHAQ and disease severity was assessed by Spearman's correlation coefficient. The reproducibility of the SHAQ was evaluated by the intraclass correlation coefficient (ICC). Among the 151 consecutive outpatients evaluated, 59 % had limited SSc subtype. The overall disease severity visual analog scale (VAS) of the SHAQ was statistically significantly correlated to HAQ-DI, pain VAS, and the SF-36v2™ physical component summary score (r = 0.595, r = 0.612, and r = −0.582, respectively; p < 0.001). Further analysis of all SF-36v2™ components revealed statistically significant correlations between overall disease severity VAS and bodily pain (r = −0.621, p < 0.001), vitality (r = −0.544, p < 0.001), physical function (r = −0.510, p < 0.001), and role limitation-physical dimensions (r = −0.505, p < 0.001). Moreover, digestive, pulmonary, and overall disease severity VASs were statistically significantly correlated to the number of organs involved (r = 0.178, p = 0.029; r = 0.214, p = 0.008; r = 0.282, p < 0.001). We also demonstrated high reproducibility for SHAQ (ICC = 0.757, 95 % confidence interval = 0.636–0.842). The Brazilian version of the SHAQ demonstrated both construct and discriminant validities as well as good reproducibility.
引用
收藏
页码:699 / 706
页数:7
相关论文
共 148 条
[1]  
Charles C(2006)Systemic sclerosis: hypothesis-driven treatment strategies Lancet 367 1683-1691
[2]  
Clements P(2010)Targeted therapy for systemic sclerosis: how close are we? Nat Rev Rheumatol 6 269-278
[3]  
Furst DE(2011)Validation of new biomarkers in systemic autoimmune diseases Nat Rev Rheumatol 7 708-717
[4]  
Ramos-Casals M(1991)The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis Arthritis Care Res 4 27-31
[5]  
Fonollosa-Pla V(1980)Measurement of patient outcome in arthritis Arthritis Rheum 23 137-145
[6]  
Brito-Zerón P(1982)The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales J Rheumatol 9 789-793
[7]  
Sisó-Almirall A(1997)The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time Arthritis Rheum 40 1984-1991
[8]  
Tektonidou MG(2001)The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial Arthritis Rheum 44 653-661
[9]  
Ward MM(2005)Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms Clin Rheumatol 24 48-54
[10]  
Poole JL(2005)Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ) Clin Rheumatol 24 3-10